"Pancreaticoduodenectomy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The excision of the head of the pancreas and the encircling loop of the duodenum to which it is connected.
| Descriptor ID |
D016577
|
| MeSH Number(s) |
E04.210.760
|
| Concept/Terms |
Pancreaticoduodenectomy- Pancreaticoduodenectomy
- Pancreaticoduodenectomies
- Pancreatoduodenectomy
- Pancreatoduodenectomies
- Duodenopancreatectomy
- Duodenopancreatectomies
|
Below are MeSH descriptors whose meaning is more general than "Pancreaticoduodenectomy".
Below are MeSH descriptors whose meaning is more specific than "Pancreaticoduodenectomy".
This graph shows the total number of publications written about "Pancreaticoduodenectomy" by people in this website by year, and whether "Pancreaticoduodenectomy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pancreaticoduodenectomy" by people in Profiles.
-
Association between Preoperative Steroids and Outcomes in Patients Undergoing Pancreaticoduodenectomy using the National Surgical Quality Improvement Program. J Gastrointest Surg. 2022 06; 26(6):1198-1204.
-
Surgical Management of Pancreatic Neuroendocrine Tumors. Surg Oncol Clin N Am. 2020 Apr; 29(2):243-252.
-
Pancreaticoduodenectomy for the Management of Pancreatic or Duodenal Metastases from Primary Sarcoma. Anticancer Res. 2018 Jul; 38(7):4041-4046.
-
En bloc right hemicolectomy/pancreaticoduodenectomy for cancer: one institution's experience. Am Surg. 2013 Jun; 79(6):E238-9.
-
Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial. Ann Surg Oncol. 2011 Feb; 18(2):337-44.
-
En bloc right hemicolectomy and pancreaticoduodenectomy for HNPCC with simultaneous mutations of MSH-2 and MSH-6. Int J Colorectal Dis. 2011 Apr; 26(4):527-9.
-
Management of a patient with borderline resectable pancreatic cancer. Case report and review. Oncology (Williston Park). 2008 Nov 30; 22(13):1524-9.
-
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol. 2008 Jul 20; 26(21):3503-10.
-
Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys. 2007 May 01; 68(1):178-82.
-
Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival. J Gastrointest Surg. 2005 Dec; 9(9):1191-204; discussion 1204-6.